ARCHIVES

NCI Criticized For Delays In Development Of New Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | January 24, 1975

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

Grassley Seeks Data On Sponsored Travel By NCI Scientists

October 29, 2010

The Clinical Cancer Letter To End Print Edition In 2010

November 27, 2009

ACS Recommends MRI For Some Women At High Risk

March 30, 2007

NCI Begins TAILORx Study.

May 26, 2006

Centers, Control to Be In New Division; Upton Moves Fink Up; Terry Acting Director Of DCCR

May 4, 1979